TechPrecision does not carry a meaningful analyst price-target consensus. MarketBeat and Benzinga report no consensus price target, and Simply Wall St lists zero analysts covering the name. The lone "sell" rating visible on some aggregators comes from a ratings service rather than a price-target-based research report. Because no credible aggregate of individual analyst targets exists, this article uses a fallback objective: public market commentary published after the company's August 2026 first-quarter report pointed to a potential $7-per-share objective over roughly 18 months, arguing that the market was still pricing the company's prior weakness rather than its improving operating results. That figure is a publicly discussed level resting on a turnaround rationale, and it is clearly identified here as commentary, not an analyst consensus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The shares have recently traded near $5.15, within a 52-week range of roughly $2.88 to $6.31. Reaching $7 would require an advance of about 36% from current levels, which is a substantial move that would take the stock decisively above its prior 52-week high. The path toward that level hinges on whether the company can sustain the improvement shown in its most recent quarter, when revenue rose 23% year over year to $9.1 million, gross profit climbed 36%, and EBITDA rose from $0.2 million to $0.7 million. Any sustained move higher would likely depend on converting a $52.7 million funded backlog into margin-accretive revenue while returning the Stadco segment to profitability.
The most important supporting factor is the company's defense exposure. Ranor's revenue grew 27% in the latest quarter, supported by more than $24 million in U.S. Navy submarine program grants that effectively pre-fund capacity expansion. A growing funded backlog, narrowing operating losses (down roughly 90% quarter over quarter), and reduced debt from $7.0 million to $5.0 million all point to a cleaner operating setup. Management has guided toward $3–4 million of EBITDA for fiscal 2027, and if Stadco's two legacy loss-making contracts clear as expected, the company could approach profitability, which would be a meaningful catalyst for a stock trading on roughly 1.6 times sales. From what I see, the defense tailwinds appear durable.
The risks are substantial and largely balance-sheet driven. TechPrecision remains unprofitable on a trailing basis, with a negative price-to-earnings (P/E) ratio and thin cash of roughly $0.3 million. The company has faced debt-covenant violations, negative working capital, and customer-furnished material delays that previously triggered steep revenue and margin declines. Stadco has not yet returned to profitability, and execution on its legacy contracts carries real uncertainty. As a micro-cap with limited liquidity and no analyst coverage, the stock is also prone to sharp, sentiment-driven swings that can work against a sustained rally.
The durable levels worth watching are straightforward. The $6.31 area marks the 52-week high and is the primary resistance level; a move to $7 would require a breakout to a new multi-year high, which is a meaningful technical milestone rather than an incremental move. On the downside, the $2.88 52-week low defines the lower bound of the recent range, while the round $5 level has acted as a rough pivot between strength and weakness. The $7 objective sits above the prior high and carries psychological significance as a round number, meaning it would likely need to be supported by fundamental news rather than momentum alone.
Because the $7 figure comes from public commentary rather than formal analyst research, no precise research horizon can be verified; the discussion that produced it referenced a period of roughly 18 months. Investors should treat that as indicative rather than a firm timetable. The most important items to monitor are upcoming quarterly results, any progress on Stadco's legacy contracts, updates to the funded backlog, changes in working capital and debt covenants, and any commentary on the path to positive EBITDA. Broader defense budget and Navy submarine procurement developments also matter for the Ranor segment. I'm watching this closely for signs of sustained execution.
Can TechPrecision stock reach $7? The target is a commentary-based objective, not an analyst consensus, and it rests on a turnaround story that is just beginning to show up in the numbers. The roughly 36% move required would take the shares to a new high, which demands sustained execution: continued revenue growth, a profitable Stadco, progress toward positive EBITDA, and a cleaner balance sheet. The supports are real—defense demand, a large funded backlog, and narrowing losses—but so are the obstacles, including covenant risk, negative working capital, and no institutional analyst coverage. Investors should weigh both sides and monitor quarterly results, backlog conversion, and debt metrics before drawing conclusions.
In my own process, Tickeron's AI Daily Buy/Sell Signals provide a useful way to stay on top of micro-caps that lack traditional coverage. The platform applies artificial intelligence to scan thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals based on technical behavior and market shifts. I find it helps surface momentum changes more efficiently than manual reviews alone, especially for names with limited liquidity.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for TPCS moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 27 of the 30 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 70 cases where TPCS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
Following a +7.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where TPCS advanced for three days, in 148 of 218 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
TPCS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TPCS as a result. In 79 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for TPCS turned negative on October 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 33 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.
TPCS moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TPCS crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TPCS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for TPCS entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: TPCS's P/B Ratio (6.643) is slightly higher than the industry average of (2.913). TPCS has a moderately low P/E Ratio (-38.385) as compared to the industry average of (9.265). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (0.744). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (1.610) is also within normal values, averaging (6248.204).
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. TPCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TPCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry MetalFabrication